Skip to main content

Day: August 20, 2020

QuestCap Announces Upsizing of Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap”) (CSE:QSC; FRA:34C1) is pleased to announce that it has increased the size of its previously announced private placement financing from $2.5 million to up to $4.5 million.  The Company will now issue up to 22,500,000 units of the Company at a purchase price of $0.20 per unit.  Each unit consists of one common share of the Company (a “Share”) and one common share purchase warrant (a “Warrant”).  Each Warrant entitles the holder thereof to acquire one Share at a price of $0.25 for a period of 24 months following the closing date. The Company previously announced that it has closed the first tranche of the private placement by issuing 7,755,500 units at a price of $0.20...

Continue reading

Calibre Completes Acquisition of Remaining 70% Interest in the Eastern Borosi Gold-Silver Property from IAMGOLD

VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) — Calibre Mining Corp. (“Calibre” or the “Company”)(TSX: CXB; OTCQX: CXBMF) is pleased to announce the closing of the transaction with IAMGOLD Corporation (“IAMGOLD”) pursuant to which Calibre has acquired IAMGOLD’s 70% interest in the Eastern Borosi Gold-Silver Property (the “Property” or “EBP”) located in northeastern Nicaragua (the “Transaction”). Consideration for IAMGOLD’s 70% interest in the EBP is payable in the form of (i) 2,253,961 common shares of Calibre (US$3 million); (ii) US$1 million in cash payable on or before August 11, 2021; and (iii) a 2.0% Net Smelter Return royalty (the “NSR Royalty”) on future production from the Property (Calibre has the right to purchase 1.0% of the NSR Royalty for US$2 million and has a right of first refusal on the remaining 1.0%...

Continue reading

POET Technologies Reports Second Quarter 2020 Financial Results

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported its unaudited condensed consolidated financial results for the second quarter ended June 30, 2020. The Company’s financial results as well as the Management Discussion and Analysis have been filed on SEDAR. All financial figures are in United States dollars (“USD”) unless otherwise indicated.Second Quarter Financial (non-IFRS) and Recent Business Highlights:Announced a Letter of Intent (LOI) with Xiamen Sanan Integrated Circuit Co. Ltd (“Sanan IC”) on the formation of a joint venture valued at $50 million;Received and accepted as final payment...

Continue reading

Performance Shipping Inc. Announces the Sale and Delivery of Vessel to Her New Owner

ATHENS, Greece, Aug. 20, 2020 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG), (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that on 19 August 2020, through a separate wholly-owned subsidiary, it signed a Memorandum of Agreement to sell the 2001-built Panamax container vessel, the M/V Domingo, to an unaffiliated third party for a sale price of US$5.6 million before commissions. The vessel was successfully delivered to her new owner today.Performance Shipping Inc.’s fleet now consists of four (4) Aframax tanker vessels.Commenting on the transaction, Mr. Andreas Michalopoulos, the Company’s Deputy Chief Executive Officer, Chief Financial Officer and Treasurer stated:“We are thrilled to announce the sale of the last remaining container ship in our fleet, which marks the...

Continue reading

Energi Danmark A/S 2020 half-yearly report

Aarhus, 20 August 2020During the first half of 2020 the Energi Danmark Group realised a profit before tax of DKK 130.6 million. This corresponds to a yearly return on equity before tax of 22%. The revenue of DKK 21.5 billion in the first half of 2020 is on the same level as the previous year.2020 was off to a challenging start with rapidly falling energy prices and the COVID-19 virus affecting the society and economy in all countries. In the 1st quarter of 2020 the sale of the subsidiary Energi Danmark Vind A/S was completed and recognized in the financial statement with an amount of DKK 147.7 million. The effect of the COVID-19 virus resulted in lower energy consumption than expected, especially in the 2nd quarter of 2020 on the German and Swedish markets, resulting in a loss for the Group. The 2020 half-year result is in line with the...

Continue reading

Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of Faculdade Ciências Médicas da Paraíba

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug. 20, 2020 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Ciências Médicas da Paraíba, or FCMPB.FCMPB is a post-secondary education institution with government authorization to offer on-campus, undergraduate courses in medicine in the State of Paraíba and medical course represents 99% of its 2019’s Net Revenue. The projected Net Revenue for FCMPB in 2024, when the institution will reach maturation, is R$107.0 million representing an estimated post synergies EV/EBITDA of 6.3x all derived from its medical school.The aggregate purchase price is R$380.0 million, of which: (i) 50% is payable in cash...

Continue reading

Genmab Announces Janssen Granted U.S. FDA Approval for DARZALEX® (daratumumab) in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Company AnnouncementDARZALEX® (daratumumab) approved by U.S. FDA in combination with carfilzomib and dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy Approval based on the Phase 3 CANDOR studyApproval marks eighth U.S. FDA approval for DARZALEXCopenhagen, Denmark; August 20, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX® (daratumumab) in combination with carfilzomib and dexamethasone (DKd) for the treatment of adult patients with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy.  A supplemental Biologics License Application (sBLA) for this indication was submitted by Genmab’s licensing partner, Janssen Biotech,...

Continue reading

Medicenna to Commence Trading on Nasdaq

TORONTO and HOUSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA) (TSX: MDNA), a clinical stage immuno-oncology company, today announced that the Company’s common shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”). Trading is expected to begin on Monday, August 24, 2020, under the symbol “MDNA” on the Nasdaq.  The Corporation will retain its listing on the Toronto Stock Exchange under the symbol “MDNA” and the Company’s common shares will continue to trade on the OTCQB under the symbol “MDNAF” until trading on the Nasdaq commences.“The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” said Fahar Merchant, PhD, President and CEO...

Continue reading

Avante Logixx Inc. to Release Results for the Quarter Ended June 30, 2020 After Market Close on Wednesday, August 26, 2020

Not for distribution to U.S. news wire services or for dissemination in the United StatesTORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Avante Logixx Inc. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) is pleased to announce that it will release its financial results for the quarter ended June 30, 2020 after market close on Wednesday, August 26, 2020 and a news release will be disseminated at that time with an earnings call at 8:30 AM EST on Thursday, August 27, 2020.CONFERENCE CALLAvante will be hosting a conference call to discuss the above financial results on Thursday, August 27, 2020, at 8:30 AM EST.This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities described herein in any jurisdiction in which such offer, solicitation or sale would be...

Continue reading

Summit Industrial Income REIT– Announces C$150 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Summit Industrial Income REIT (“Summit” or the “REIT”) (TSX: SMU.UN) announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets (collectively, the “Underwriters“) to sell, on a bought deal basis, 12,500,000 Units at a price of $12.00 per Unit for gross proceeds to Summit of approximately $150 million (the “Offering“). In addition, Summit has granted the Underwriters an over-allotment option to purchase up to an additional 1,875,000 Units on the same terms and conditions, exercisable at any time, in whole or in part, up to 30 days after the closing of the Offering. The Offering is expected to close on or about August...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.